Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 8/20 | 0.41 |
| ▸ | ADRA2C | P18825 | 7/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | PRKCI | P41743 | 1/20 | 0.35 |
| ▸ | CSNK2A2 | P19784 | 2/20 | 0.34 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.34 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.34 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.34 |
| ▸ | RAD52 | P43351 | 1/20 | 0.34 |
| ▸ | ADRA1D | P25100 | 6/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 6/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30945080 | 1.00 | ADRA2A (0.41) | ADRA2AADRA2CMEN1KMT2AKDM4E | |
| SCHEMBL15834705 | 0.78 | LMNA (0.44) | MEN1KMT2AKDM4EMAPTALDH1A1 | |
| SCHEMBL1374558 | 0.78 | PRKCI (0.44) | MEN1KMT2AKDM4EMAPTALDH1A1 | |
| SCHEMBL5571160 | 0.77 | MAPKAPK2 (0.40) | KDM4EALDH1A1CSNK2A1RAB9AHPGD | |
| SCHEMBL35938 | 0.76 | LMNA (0.54) | KDM4EMAPTALDH1A1POLBRAB9A | |
| SCHEMBL29382312 | 0.76 | LMNA (0.54) | KDM4EMAPTALDH1A1POLBRAB9A | |
| SCHEMBL192176 | 0.76 | KDM4E (0.41) | MEN1KMT2AKDM4EMAPTALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL29846072 | 0.75 | LMNA (0.52) | KDM4EMAPTALDH1A1POLBRAB9A | |
| SCHEMBL28400795 | 0.75 | LMNA (0.52) | KDM4EMAPTALDH1A1POLBRAB9A | |
| Ammonia Solution, Strong SCHEMBL27979217 | 0.75 | LMNA (0.52) | KDM4EMAPTALDH1A1POLBRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1489 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115989214-B | Pigment composition, inkjet recording method, image recorded matter, and pigment compound | 富士胶片株式会社 | 2025-02-25 | — | — | CN | claimed |
| US-20230173071-A1 | TREATMENT OF MYOPIA AND OTHER OCULAR CONDITIONS USING SINGLET OXYGEN GENERATED FROM DYES ACTIVATED BY NEAR-INFRARED LIGHT | CALIFORNIA INST OF TECHN (US) | 2023-06-08 | — | — | US | claimed |
| EP-2758075-B1 | INFLUENZA VIRUS VACCINES AND USES THEREOF | ICAHN SCHOOL MED MOUNT SINAI (US) | 2023-05-03 | — | — | EP | claimed |
| EP-2934581-B1 | INFLUENZA VIRUS VACCINES AND USES THEREOF | ICAHN SCHOOL MED MOUNT SINAI (US) | 2022-09-14 | — | — | EP | claimed |
| US-20220242920-A1 | IMMUNOGENIC COMPOSITION | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2022-08-04 | — | — | US | claimed |
| CN-113286788-A | Treatment of myopia and other eye disorders using singlet oxygen | 加州理工学院 | 2021-08-20 | — | — | CN | claimed |
| US-20200129620-A1 | Treatment Of Myopia And Other Ocular Conditions Using Singlet Oxygen Generated From Dyes Activated By Near-Infrared Light | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2020-04-30 | — | — | US | claimed |
| US-20200131370-A1 | Near-Infrared Heptamethine Dyes For Generation Of Singlet Oxygen | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2020-04-30 | — | — | US | claimed |
| US-10583188-B2 | Influenza virus vaccines and uses thereof | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2020-03-10 | — | — | US | claimed |
| US-20190214577-A1 | THERMALLY ACTIVATED DELAYED FLUORESCENCE MATERIAL, POLYMER, MIXTURE, FORMULATION, AND ORGANIC ELECTRONIC DEVICE | GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) | 2019-07-11 | — | — | US | claimed |
| US-4440929-A | Imidazoquinoxaline compounds | USV PHARMACEUTICAL CORPORATION (US) | 1984-04-03 | — | — | US | claimed |
| US-4375508-A | ACETHYLENIC HYDROCARBON CHAIN | EASTMAN KODAK COMPANY (US) | 1983-03-01 | — | — | US | claimed |
| EP-0070518-A2 | Imidazoquinoxaline compounds | RORER INTERNATIONAL (OVERSEAS) INC. (US) | 1983-01-26 | — | — | EP | claimed |
| US-4254123-A | FOR TREATMENT OF ASTHMA; ANTIALLERGENS | ROUSSEL UCLAF (FR) | 1981-03-03 | — | — | US | claimed |
| US-4254198-A | Electrophotosensitive materials for migration imaging processes | EASTMAN KODAK COMPANY (US) | 1981-03-03 | — | — | US | claimed |
| US-4166740-A | CYANINE DYES | EASTMAN KODAK COMPANY (US) | 1979-09-04 | — | — | US | claimed |
| US-RE29930-E | HIGH SPEED | EASTMAN KODAK COMPANY (US) | 1979-03-13 | — | — | US | claimed |
| US-4108667-A | Photographic compositions and elements containing benzo[a]quinolizinium methine dyes | EASTMAN KODAK COMPANY (US) | 1978-08-22 | — | — | US | claimed |
| US-RE29575-E | Cubic regular grain photographic reversal emulsions | EASTMAN KODAK COMPANY (US) | 1978-03-14 | — | — | US | claimed |
| US-3935010-A | IMIDAZOQUINOXALINE DESENSITIZER | EASTMAN KODAK COMPANY (US) | 1976-01-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220242920-A1 | IMMUNOGENIC COMPOSITION | HIRA, HSPA1A, HSPA8 | ADRA2A 4133/4885ADRA2C 4645/4885MEN1 4372/4885 |
| US-20190214577-A1 | THERMALLY ACTIVATED DELAYED FLUORESCENCE MATERIAL, POLYMER, MIXTURE, FORMULATION, AND ORGANIC ELECTRONIC DEVICE | TEAD2, TEAD3, TEAD1 | ADRA2A 2703/4885ADRA2C 3436/4885MEN1 4137/4885 |
| US-20200129620-A1 | Treatment Of Myopia And Other Ocular Conditions Using Singlet Oxygen Generated From Dyes Activated By Near-Infrared Light | CRY1, MYH10, MYLK | ADRA2A 423/4885ADRA2C 985/4885MEN1 716/4885 |
| US-20230173071-A1 | TREATMENT OF MYOPIA AND OTHER OCULAR CONDITIONS USING SINGLET OXYGEN GENERATED FROM DYES ACTIVATED BY NEAR-INFRARED LIGHT | CRY1, MYH10, MYLK | ADRA2A 423/4885ADRA2C 985/4885MEN1 716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.